When big pharma company
Pfizer
reports earnings on Tuesday, before the market opens, all eyes will be on the guidance the company issues for 2023, and how steeply
Pfizer
expects Covid-19 vaccine sales to drop this year.
Wall Street analysts expect Pfizer (ticker: PFE) to earn $4.33 per share in 2023, according to FactSet, down from the $6.50 per share they estimate the company earned in 2022. Analysts expect Pfizer to earn $1.05 per share in the fourth quarter on sales of $24.4 billion, compared with year-ago earnings $1.08 per share on sales of $23.8 billion. The company is hosting an investor call at 10 a.m. eastern time.